The Veterinary anti-infectives market Share is expected to experience a CAGR of 4.1% and reach US $ 368 million between 2025. The current scenario is that mobile technology has improved patient care and empowered clinicians. The scenario is expected to continue even into the future. Tech-savvy patients have emerged and digitally transformed the healthcare industry.
In recent years, reports of deadly animal disease outbreaks have become more common. These diseases are not only a threat to the existence of many wildlife species, but also cause significant losses of livestock.
The prevention and treatment of these diseases are key market indicators for veterinary therapeutics, including veterinary anti-infectives. In its latest report, Persistence Market Research predicted that the global veterinary anti-infectives market will grow at a 4.1% CAGR over the forecast period (2017-2025) and achieve a valuation of $ 5,221.2 million by the end of 2025.
Get started with a sample report on the Veterinary Anti-Infectives Market! https://www.persistencemarketresearch.co/samples/17014
- Bayer AG
- Cipla Limited
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company (Elanco Animal Health)
- Heska Corp (Diamond Animal Health)
- Merck & Co., Inc. (Merck Animal Health)
- Neogen Corporation
- Phibro Animal Health Society
- Sanofi (Merial Animal Health)
- Vétoquinol SA
- Virbac SA
- Zoetis, Inc.
- Boehringer Ingelheim GmbH
- Ceva Animal Health
- Indian Immunologicals Limited
- Intas Pharmaceuticals Limited
- Norbrook Laboratories Limited
- Zydus Animal Health Limited
- Ashish Life Science Private Limited
- Oceanic Pharmachem Private Limited.
How about reinventing the methodical wheel in the veterinary anti-infectives market? Go to the “Methodology” tab! https://www.persistencemarketresearch.co/methodology/17014
The increasing demand for antimicrobial agents is expected to contribute significantly to the market revenue growth in the near future. The increase in the herd may stimulate the demand for veterinary therapeutics globally.
In 2014, the Food and Agriculture Organization of the United Nations estimated the number of cattle in the world at more than 1.5 billion. These numbers are expected to increase significantly further due to the rapid growth in demand for livestock.
North America will remain the world leader in veterinary anti-infectives
North America is currently the largest veterinary anti-infectives market and is expected to account for a 30.5% global market value share by 2025, with an expansion of 3.7% CAGR.
This growth is mainly due to the increase in the number of pet owners and the demand for high quality meat in the United States and Canada. Meanwhile, Latin America will continue to be the second most attractive market during the forecast period. The Asia-Pacific (APAC) market is expected to experience the fastest growth in 2025.
Keeping an eye on key players in the Veterinary Anti-Infectives market? Navigate to “Buy Now” to decipher the competitive analysis of our Veterinary Anti-Infectives Market report! https://www.persistencemarketresearch.com/checkout/17014
Additional highlights of the report include:
Based on the types of species, the use of veterinary anti-infective drugs is relatively higher in farm animals than in pets. In 2016, farm animals accounted for over 68% of the market share by value, but this figure is expected to drop to 67.4% by the end of 2025.
Antimicrobial agents are currently the most preferred type of drug. At the end of the forecast period, antimicrobial agents are expected to account for 54.6% of the market share by value. Other drugs such as antifungal agents and antiviral agents are also gaining ground due to the improvement and effectiveness of the products.
Based on the modes of administration, the oral route is currently the most common route of drug administration, followed by the parenteral route. By the end of 2025, the oral administration segment is expected to reach a market valuation of US $ 1,573.1 million.
Veterinary clinics are expected to be the main distribution channel for veterinary anti-infectives in 2017 and beyond. In recent times, veterinary hospitals and pharmacies have become the other two key distribution channels for various veterinary drugs, including anti-infective.
Explore the extensive coverage of persistence market research Health industry
Post-Herpetic Neuralgia Treatment Market:
The global postherpetic neuralgia treatment market The Post-Herpetic Neuralgia Treatment report further projects significant growth potential of the Post-Herpetic Neuralgia Treatment market. postherpetic neuralgia with a CAGR set at 5.3% until 2026.
Disposable Cystoscopes Market:
Mainly used for the early detection and treatment of prostate and bladder cancer as they minimize side effects associated with treatment, disposable cystoscopes will experience increasing demand due to the reduction of possible risks of nosocomial infections.
Active Pharmaceutical Ingredients Market:
According to the revised report published by Persistence Market Research, the active pharmaceutical ingredients market valued at around US $ 180 billion in 2020, and is expected to increase at a CAGR of over 4% during the forecast period (2021-2031).
Persistence Market Research is here to provide businesses with a one stop solution to improve customer experience. It is committed to gathering the appropriate feedback after going through personalized interactions with customers to add value to the customer experience by acting as the “missing” link between “customer relationships” and “business results”. “. The best possible returns are guaranteed there.
Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 USA
US Phone – + 1-646-568-7751
United States-Canada Toll Free – +1 800-961-0353
Sales – firstname.lastname@example.org
Website – https://www.persistencemarketresearch.com